Aspen Pharmacare shares jumped the most in 23 years on Wednesday after SA’s largest generic drugmaker painted a rosy picture heading into the second half of the financial year and beyond.

The shares jumped 13.29% to close at R160.75 on the JSE, adding R8.4bn in market value...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.